Redhill Biopharma股票討論區

$Redhill Biopharma(RDHL.US)$ RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study Of RHB-107 (Upamostat), The Study Is Expected To Be Completed By The End Of 2024

RedHill Biopharma's New Patent: A Potential Game-Changer in the Fight Against Coronavirus.
In a significant development in the medical community, RedHill Biopharma Ltd ($RDHL) has been granted US patent number 11,918,560, titled "Serine Protease Inhibitor for Treating Coronavirus Infection". The implications of this breakthrough could be far-reaching, potentially reshaping our approach to managing and treating coronavirus infections. $Redhill Biopharma(RDHL.US)$
...

$Redhill Biopharma(RDHL.US)$ Redhill Biopharma And Apogee Biotechnology's Opaganib Selected By U.S. Government's Chemical Medical Countermeasures Program And Chemical Countermeasures Research Program For A Potential Medical Countermeasure Against Inhalation Sulfur Mustard Exposure

$Redhill Biopharma(RDHL.US)$ RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs

$Redhill Biopharma(RDHL.US)$ RedHill Biopharma Will Be Issued U.S. Patent Number 11,918,560 Tomorrow Titled "Serine Protease Inhibitor For Treating Coronavirus Infection"